A part of Watch Media

MedWatchSaturday4 February 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
17/05/2022at 09:46

Sonova sales surpass analyst expectations in annual report

Demand for hearing solutions is on the rise, supporting a market upswing, says the world’s biggest hearing aid manufacturer, which has just handed in its sales figures for the financial year 2021/2022.
Photo: Sonova / PR
by marketwire, translated by daniel pedersen

Swiss Sonova, the world’s biggest hearing aid manufacturer, has just released its annual report spanning 2021/2022, in which the firm reports solid sales growth.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters

Get full access for you and your coworkers

Start a free company trial today

Related articles:

  • Photo: GN Store Nord / PR

    Demant and GN gain ground at Veterans Affairs in April

    For subscribers

  • Photo: Projekt Bear

    Pent-up demand for hearing aids continues to boost sales in US

    For subscribers

  • Photo: Dado Ruvic/REUTERS / X02714

    Analyst "positively surprised" by Demant's Q1 development

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Foto: MedWatch
Other

Top news from MedWatch this week

Miss anything?
Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology
Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Foto: Coloplast/pr
Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Foto: Coloplast / Pr
Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix
Medtech

Another hurdle overcome in delaying MDR deadline

For subscribers

Foto: Stine Tidsvilde
Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

For subscribers

Further reading

Foto: Tidsvilde Stine/Ritzau Scanpix
Pharma & biotech

Novo Nordisk declared world's best place to work in 2022

The Best Places to Work organization has released its 2022 list of the best workplaces across the world, and Danish Novo Nordisk shines at the top.

For subscribers

Photo: Novo Nordisk / Pr
Pharma & biotech

Novo Nordisk CEO rakes in cash in record year

Being at the top of Denmark’s most valuable company is lucrative, Novo Nordisk reveals in its annual report – and Chief Executive Lars Fruergaard Jørgensen is making a killing there.

For subscribers

Lars Fruergaard Jørgensen, CEO at Novo Nordisk | Foto: Stine Bidstrup
Pharma & biotech

Potential blockbuster submitted by Novo Nordisk for European approval

The EMA can begin reviewing hemophilia treatment concizumab, which used to carry the orphan drug badge until recently, when the company decided not to take advantage of the status.

For subscribers

Latest news

  • Top news from MedWatch this week – 3 Feb
  • Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps – 3 Feb
  • China accepts regulatory filing for ALK allergy tablet – 3 Feb
  • Another hurdle overcome in delaying MDR deadline – 3 Feb
  • Dupixent becomes ninefold blockbuster – 3 Feb
  • ALK forecasts lower growth in 2023 than strong 2022 result – 3 Feb
  • Unilabs and Siemens Healthineers enter million-euro strategic partnership – 3 Feb
  • Coloplast launches male catheter featuring new technology – 3 Feb
  • Novo Nordisk hopes to retain employees with share gift – 3 Feb
  • Coloplast's bottom line disappoints in otherwise strong report – 3 Feb
See all

Jobs

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Experienced Patent Counsel

  • Senior Clinical Project Manager

  • Sr. Director, Drug Safety Physician

  • Commercial Director

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Medical Advisor (Metabolism)

  • Application Manager

  • Clinical Operational Associate

  • Supply Chain Manager

  • Lead Data Architect

  • Regulatory Affairs Professional

  • Application Manager

See all jobs

Jobs

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Experienced Patent Counsel

  • Senior Clinical Project Manager

  • Sr. Director, Drug Safety Physician

  • Commercial Director

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Medical Advisor (Metabolism)

  • Application Manager

  • Clinical Operational Associate

  • Supply Chain Manager

  • Lead Data Architect

  • Regulatory Affairs Professional

  • Application Manager

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge